Monoclonal antibodies are a biological reagent that must be custom made by specialized vendors. They are prepared to the specifications for their specific use. Here they will be used as a core…
Ended Purchase Order Awarded Last action
- Contract number
- 1232SA26P0005
- Awardee
-
Green Mountain Antibodies, Inc. UEI FVQDNC5PJ5P3
- Awarding agency
-
Central Program Planning Coordination and Support
Agricultural Research Service, Department of Agriculture
- Obligated
- $60,240
Award facts
- Opportunity
-
- Monoclonal Antibody production Solicitation · 1232SA26Q0007 · Posted Nov 5, 2025
- Contract value 100% obligated
- $60,240.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Southeast Area Field Research Implementation and Information Delivery, Department of Agriculture
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Athens, GA 30605, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $6,900 | |
| Original award | $53,340 |
About this award
The USDA Agricultural Research Service (ARS) awarded a purchase order to Green Mountain Antibodies Inc., a small business, for $60,240 on November 19, 2025, for monoclonal antibody production targeting H5 highly pathogenic avian influenza.
Work is performed at the US National Poultry Research Center in Athens, Georgia. The order calls for development of monoclonal antibodies specific to two antigens containing influenza A clade 2.3.4.4b lineage H5 hemagglutinin protein for use in diagnostic assays for HPAI surveillance. Deliverables include 4 mg of purified monoclonal antibodies (1 mg from each of two clones for each of two antigens) and four vials of viable hybridomas. Performance runs through August 31, 2026, with the solicitation issued November 5, 2025, and quotes due November 12, 2025.
Description
Monoclonal antibodies are a biological reagent that must be custom made by specialized vendors. They are prepared to the specifications for their specific use. Here they will be used as a core component of a diagnostic test for H5 highly pathogenic a
Quick answers
Who was awarded contract 1232SA26P0005?
1232SA26P0005 was awarded to Green Mountain Antibodies, Inc. by Central Program Planning Coordination and Support (Agricultural Research Service) on November 19, 2025.
How much is contract 1232SA26P0005 worth?
The government has obligated $60,240 on 1232SA26P0005.
Which agency awarded contract 1232SA26P0005?
Central Program Planning Coordination and Support (Agricultural Research Service) awarded 1232SA26P0005, with funding from Southeast Area (Field Research Implementation and Information Delivery).
Was contract 1232SA26P0005 competed?
The extent of competition for 1232SA26P0005 was competed under sap. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award